Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na+-ATPase activity via a A779-sensitve receptor

被引:41
作者
Lara, LS [1 ]
Bica, RBS [1 ]
Sena, SLF [1 ]
Correa, JS [1 ]
Marques-Fernandes, MF [1 ]
Lopes, AG [1 ]
Caruso-Neves, C [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil
基金
巴西圣保罗研究基金会;
关键词
Na+-ATPase; angiotensin-(1-7); angiotensin II; furosemide; proximal tubule;
D O I
10.1016/S0167-0115(01)00322-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, we demonstrated that the stimulatory effect of Ang II on the Na+-ATPase activity in proximal tubules is reversed, in a dose-dependent manner, by Ang-(1-7) [Biochim. Biophys. Acta 1467 (2000) 189]. In the present paper, we characterized the receptor involved in this phenomenon. The preincubation of the Na+-ATPase with 10(-8) M Ang II increases the enzyme activity from 7.50 +/- 0.02 (control) to 12.40 +/- 1.50 nmol Pi mg(-1) min(-1) (p < 0.05). Addition of 10(-9) M Ang-(1-7),completely reverts this effect returning the ATPase activity to the control level. This effect seems to be specific to Ang-(1-7) since Ang III (10(-12)-10(-8) M) does not modify the stimulation of the renal proximal tubule Na+-ATPase activity by Ang II. Saralasin abolishes the Ang-(1-7) effect in a dose-dependent manner being the maximal effect obtained at 10(-11) M. The increase in A779 concentration (from 10(-12) to 10(-7) M), a specific Ang-(1-7) antagonist, also abolishes the Ang-(1-7) effect. On the other hand, PD123319 (10(-8)-10(-6) M), an AT(2) antagonist receptor, and losartan (10(-12)-10(-7) M), an AT(1) antagonist receptor, does not modify the effect of Ang-(1-7). Taken together, these data indicate that Ang-(1-7) reverts the stimulatory effect of Ang II on the Na+-ATPase activity in proximal tubule through a A779-sensitive receptor. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 43 条
[1]  
Ardaillou R, 1999, J AM SOC NEPHROL, V10, pS30
[2]  
ARENSTEIN IR, 1995, J MEMBRANE BIOL, V146, P47
[3]  
BARACHO NCV, 1995, HYPERTENSION, V25, P1408
[4]   Ouabain-insensitive Na+-ATPase activity is an effector protein for cAMP regulation in basolateral membranes of the proximal tubule [J].
Caruso-Neves, C ;
Rangel, LBA ;
Vives, D ;
Vieyra, A ;
Coka-Guevara, S ;
Lopes, AG .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1468 (1-2) :107-114
[5]   Bradykinin modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule [J].
Caruso-Neves, C ;
Siqueira, ASE ;
Iso-Cohen, G ;
Lopes, AG .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1999, 1431 (02) :483-491
[6]   Angiotensin-(1-7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule [J].
Caruso-Neves, C ;
Lara, LS ;
Rangel, LBA ;
Grossi, AL ;
Lopes, AG .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1467 (01) :189-197
[7]   Effect of adenosine on the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule [J].
CarusoNeves, C ;
FranciscoPedro, LG ;
Souza, LP ;
Chagas, C ;
Lopes, AG .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1329 (02) :336-344
[8]  
CESAR KR, 1995, HYPERTENSION, V25, P1408
[9]   PARTIAL CHARACTERIZATION OF THE OUABAIN-INSENSITIVE, NA+-STIMULATED ATPASE ACTIVITY OF KIDNEY BASAL-LATERAL PLASMA-MEMBRANES [J].
DELCASTILLO, JR ;
MARIN, R ;
PROVERBIO, T ;
PROVERBIO, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 692 (01) :61-68
[10]  
DELLIPIZZI AM, 1994, BRIT J PHARMACOL, V111, P1